| Code | 80145 | ||||||||||
| MA number | 44/0634/08-S | ||||||||||
| Product Form: | con inf 1x15 ml/300 mg (liek.inj.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Viatris Limited, Ireland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | brown glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 27.11.2008 |
| SPC: |
SPC_Irinotecan Viatris 20 mg_ml_11.2023.pdf
|
| PIL: |
PIL_Irinotecan Viatris 20 mg_ml_11.2023.pdf
|
| Safety feature | Yes |
| Data update: | 15.11.2023 |
